Spalding study urges routine sleep checks for kids with brain tumors
Researchers found that excessive daytime sleepiness is common in these patients but often goes untested, potentially affecting cognitive assessments.
By Adrian Romano ·

Sleep disruptions in children with brain tumors are frequently treated as a standard side effect of cancer care, but new research suggests these issues may require more specific medical attention. Dr. Kayla LaRosa, an assistant professor in the School of Professional Psychology at Spalding University, led a study indicating that excessive daytime sleepiness is more prevalent and treatable than many clinicians assume.
The research team identified younger children, specifically those under the age of six, as being at increased risk for these sleep-related symptoms. While drowsiness is often attributed to treatment protocols, the study found that symptoms frequently warrant evaluation by sleep specialists rather than simple monitoring. The work aims to encourage healthcare providers to make sleep screening a routine component of pediatric cancer treatment.
Dr. LaRosa noted that the research emerged from repeated observations in clinical settings. “As a psychologist working with cancer patients, sleep problems were something we kept seeing over and over again,” she said. The research team determined that poor sleep quality affects not just the child, but the entire family unit. They emphasized that evidence-based interventions exist to address these issues and improve daily functioning.
Tumors can develop near brain regions that regulate sleep and wake cycles, making these patients particularly vulnerable to disturbances. The study found that healthy sleep is linked to improvements in mood, pain management, and school engagement. Some existing research has also suggested connections between sleep health and cancer treatment outcomes, reinforcing the need for better sleep hygiene in this population.
A major gap identified by the researchers is the lack of standardized guidelines for managing excessive daytime sleepiness in this specific group. While guidance exists for general cancer-related fatigue or conditions like narcolepsy, there is no widely accepted roadmap for excessive daytime sleepiness in children with brain tumors. Dr. LaRosa’s team used validated assessment tools to determine when behavioral interventions or specialist referrals were necessary.
The project has also engaged students in the Pediatric Understanding of Life, Sleep, and Environment, or PULSE, Research Interest Group. Participants have contributed to data analysis, manuscript preparation, and conference presentations. Former research assistant Keerthi Narasimhan contributed to the initial work, while current students Will Keller, Callie Saperston, and Liza Edwards-Levin continue to advance the scholarship.
Callie Saperston recently completed a secondary analysis of sleep concerns among pediatric brain tumor patients undergoing neuropsychological evaluations. Her findings suggest that unrecognized sleep issues may influence cognitive assessments. If these issues are not routinely evaluated, they could contribute to misdiagnosis. Saperston will present her research at the International Neuropsychological Society Conference in Boston.
The conference is scheduled for February 10 through 13, 2027. Dr. LaRosa’s team hopes the research encourages families to speak up about sleep difficulties rather than treating them as a secondary concern. “There’s so much to worry about during cancer treatment that sleep can sometimes feel like a secondary concern,” LaRosa said. She noted that improving sleep can have a major impact on quality of life and coping mechanisms.
The ongoing research continues to explore how healthcare providers can better identify and address these symptoms. The goal is to help children with brain tumors receive more comprehensive and supportive care. The study provides a basis for clinicians to ask specific questions about sleep patterns during routine appointments.






